

A practical guide for providers on helping patients find Claritin (Loratadine) in stock, manage alternatives, and navigate OTC allergy medication access.
When patients come to your office reporting they can't find Claritin (Loratadine) at their pharmacy, it can feel like a small problem — but for patients suffering from allergic rhinitis or chronic urticaria, uninterrupted access to their antihistamine matters. As a provider, you're well-positioned to help patients navigate availability challenges, consider appropriate alternatives, and access the tools they need to find their medication.
This guide provides practical, actionable steps you can take to support your patients when they're having trouble finding Claritin or Loratadine in 2026.
Claritin (Loratadine) is not in shortage as of 2026. It is not listed on the FDA Drug Shortage Database or the ASHP shortage list. Loratadine benefits from:
However, seasonal demand spikes during peak allergy periods (March–June, September–November) can cause temporary stock-outs at individual retail locations. This is the most common scenario your patients are encountering.
Understanding why patients report difficulty finding Claritin helps you provide targeted guidance:
Claritin is available in numerous formulations: 24-hour tablets, RediTabs, Liqui-Gels, chewable tablets, children's syrup, and Claritin-D. While standard generic Loratadine tablets are almost always available, specialty formulations have more limited shelf space and sell out faster. Patients — particularly parents seeking children's formulations — may struggle to find their preferred product.
A surprising number of patients are unaware that generic Loratadine is therapeutically equivalent to brand-name Claritin. They may search exclusively for the Claritin brand and overlook store-brand or generic alternatives sitting on the next shelf.
Claritin-D products contain Pseudoephedrine and are stored behind the pharmacy counter in most states. Patients must request them from the pharmacist and may face purchase quantity limits. Some patients interpret this regulated access as a shortage.
During high-pollen weeks, retail locations in heavily affected regions can sell through their antihistamine inventory rapidly. Chain pharmacies may take several days to restock between shipments.
Take a moment during allergy-related visits to explicitly state that generic Loratadine is identical to brand-name Claritin. Many patients trust this information more when it comes directly from their provider. Key talking points:
Direct patients to Medfinder, a free tool that lets them search for medication availability at pharmacies near their zip code. This eliminates the need to call multiple pharmacies or drive from store to store. Consider adding Medfinder to your patient handouts or discharge instructions for allergy visits.
When recommending Loratadine, briefly mention alternative OTC antihistamines so patients have backup options if they can't find their preferred medication:
Providing this information upfront empowers patients to make appropriate switches independently rather than going without treatment.
Since Loratadine is OTC, most insurance plans don't cover it. Some patients — especially those transitioning from prescription allergy medications — may face unexpected out-of-pocket costs. Helpful guidance includes:
If a patient reports persistent difficulty controlling allergy symptoms despite appropriate OTC antihistamine use, consider:
When patients need to switch from Loratadine, here's a quick clinical comparison to guide your recommendations:
For a patient-facing resource on alternatives, you can share our article on alternatives to Claritin.
Integrate these practices into your allergy management workflow:
Claritin (Loratadine) is widely available in 2026 with no formal shortage. When patients report difficulty finding it, the most effective interventions are education about generic equivalence, providing availability tools like Medfinder, and ensuring patients know about alternative antihistamines they can access independently.
By proactively addressing availability and cost concerns during allergy visits, you can reduce patient frustration, prevent treatment gaps, and improve adherence to allergy management plans.
For the latest on Claritin availability trends, see our provider shortage briefing for 2026. For cost-saving resources to share with patients, see our guide on how to help patients save money on Claritin.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.